$210 Million is the total value of Sio Capital Management, LLC's 58 reported holdings in Q2 2017. The portfolio turnover from Q1 2017 to Q2 2017 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| QTNT | Buy | QUOTIENT LTD | $17,407,000 | +6.5% | 2,365,100 | +1.2% | 8.27% | -9.5% |
| JNJ | Buy | JOHNSON & JOHNSONput | $9,260,000 | +147.8% | 70,000 | +133.3% | 4.40% | +110.5% |
| SNY | Sell | SANOFI SAsponsored adr | $8,702,000 | -28.9% | 181,622 | -32.8% | 4.14% | -39.6% |
| ISRG | New | INTUITIVE SURGICAL INCput | $8,605,000 | – | 9,200 | +100.0% | 4.09% | – |
| AET | Buy | AETNA INC | $7,895,000 | +66.8% | 52,000 | +40.2% | 3.75% | +41.7% |
| ACOR | Sell | ACORDA THERAPEUTICS INCput | $7,486,000 | -65.9% | 380,000 | -63.7% | 3.56% | -71.0% |
| AGN | New | ALLERGAN PLCput | $7,293,000 | – | 30,000 | +100.0% | 3.47% | – |
| PHG | Sell | KONINKLIJKE PHILIPS NVny reg sh new | $7,006,000 | -10.6% | 195,586 | -19.9% | 3.33% | -24.1% |
| PBYI | Sell | PUMA BIOTECHNOLOGY INC | $6,994,000 | +17.5% | 80,021 | -50.0% | 3.32% | -0.2% |
| LPNT | New | LIFEPOINT HEALTH INCput | $6,715,000 | – | 100,000 | +100.0% | 3.19% | – |
| TMO | Buy | THERMO FISHER SCIENTIFIC INC | $6,275,000 | +36.2% | 35,965 | +19.9% | 2.98% | +15.7% |
| HCA | New | HCA HEALTHCARE INC | $5,269,000 | – | 60,420 | +100.0% | 2.50% | – |
| SGEN | New | SEATTLE GENETICS INCput | $5,174,000 | – | 100,000 | +100.0% | 2.46% | – |
| ABBV | New | ABBVIE INCput | $5,076,000 | – | 70,000 | +100.0% | 2.41% | – |
| GSK | Sell | GLAXOSMITHKLINE PLCsponsored adr | $4,877,000 | -55.8% | 113,113 | -56.7% | 2.32% | -62.4% |
| SAGE | Sell | SAGE THERAPEUTICS INCput | $4,778,000 | -34.6% | 60,000 | -41.6% | 2.27% | -44.4% |
| TRHC | Sell | TABULA RASA HEALTHCARE INC | $4,705,000 | -15.7% | 312,630 | -24.5% | 2.24% | -28.4% |
| INSM | Buy | INSMED INCput | $4,575,000 | +207.5% | 266,600 | +213.6% | 2.17% | +161.3% |
| AGIO | New | AGIOS PHARMACEUTICALS INCput | $4,275,000 | – | 83,100 | +100.0% | 2.03% | – |
| AAAP | ADVANCED ACCELERATOR APPLICATIONS SAsponsored ads | $4,237,000 | -2.1% | 108,523 | 0.0% | 2.01% | -16.8% | |
| HYH | New | HALYARD HEALTH INC | $3,952,000 | – | 100,599 | +100.0% | 1.88% | – |
| UNH | UNITEDHEALTH GROUP INC | $3,922,000 | +13.1% | 21,151 | 0.0% | 1.86% | -3.9% | |
| GMED | Buy | GLOBUS MEDICAL INCcl a | $3,759,000 | +111.5% | 113,400 | +89.0% | 1.79% | +79.7% |
| RIGL | Sell | RIGEL PHARMACEUTICALS INC | $3,674,000 | -41.2% | 1,345,723 | -28.7% | 1.75% | -50.1% |
| PKI | New | PERKINELMER INC | $3,673,000 | – | 53,899 | +100.0% | 1.74% | – |
| REGN | New | REGENERON PHARMACEUTICALS INCput | $3,438,000 | – | 7,000 | +100.0% | 1.63% | – |
| LLY | New | ELI LILLY AND COput | $3,292,000 | – | 40,000 | +100.0% | 1.56% | – |
| LLY | Sell | ELI LILLY AND CO | $2,755,000 | -43.3% | 33,473 | -42.1% | 1.31% | -51.8% |
| SNN | SMITH & NEPHEW PLCspdn adr new | $2,692,000 | +12.7% | 77,244 | 0.0% | 1.28% | -4.3% | |
| MDT | MEDTRONIC PLC | $2,663,000 | +10.2% | 30,000 | 0.0% | 1.26% | -6.4% | |
| HCA | New | HCA HEALTHCARE INCput | $2,616,000 | – | 30,000 | +100.0% | 1.24% | – |
| ANTM | New | ANTHEM INC | $2,590,000 | – | 13,767 | +100.0% | 1.23% | – |
| MZOR | Buy | MAZOR ROBOTICS LTDsponsored ads | $2,557,000 | +172.9% | 73,948 | +135.0% | 1.22% | +131.9% |
| NTUS | New | NATUS MEDICAL INC | $2,540,000 | – | 68,095 | +100.0% | 1.21% | – |
| NVRO | New | NEVRO CORP | $2,475,000 | – | 33,250 | +100.0% | 1.18% | – |
| LMNX | New | LUMINEX CORP | $2,449,000 | – | 115,979 | +100.0% | 1.16% | – |
| ELGX | New | ENDOLOGIX INC | $2,396,000 | – | 493,060 | +100.0% | 1.14% | – |
| CCXI | Sell | CHEMOCENTRYX INC | $2,292,000 | +7.1% | 244,850 | -16.8% | 1.09% | -9.1% |
| VRAY | New | VIEWRAY INC | $2,031,000 | – | 313,947 | +100.0% | 0.96% | – |
| PEN | New | PENUMBRA INCput | $1,755,000 | – | 20,000 | +100.0% | 0.83% | – |
| ACAD | New | ACADIA PHARMACEUTICALS INCput | $1,673,000 | – | 60,000 | +100.0% | 0.80% | – |
| CBIO | New | CATALYST BIOSCIENCES INC | $1,642,000 | – | 353,172 | +100.0% | 0.78% | – |
| MED | New | MEDIFAST INCput | $1,597,000 | – | 38,500 | +100.0% | 0.76% | – |
| VCRA | Buy | VOCERA COMMUNICATIONS INC | $1,482,000 | +19.7% | 56,106 | +12.5% | 0.70% | +1.7% |
| ZYNE | New | ZYNERBA PHARMACEUTICALS INC | $1,193,000 | – | 70,300 | +100.0% | 0.57% | – |
| ARNA | New | ARENA PHARMACEUTICALS INC | $1,170,000 | – | 69,352 | +100.0% | 0.56% | – |
| CLVS | New | CLOVIS ONCOLOGY INC | $1,170,000 | – | 12,500 | +100.0% | 0.56% | – |
| STDY | New | STEADYMED LTD | $1,058,000 | – | 168,000 | +100.0% | 0.50% | – |
| AVDL | AVADEL PHARMACEUTICALS PLCsponsored adr | $1,008,000 | +13.9% | 91,413 | 0.0% | 0.48% | -3.2% | |
| AXSM | Sell | AXSOME THERAPEUTICS INC | $880,000 | +7.4% | 160,000 | -23.8% | 0.42% | -8.7% |
| AXGT | New | AXOVANT SCIENCES LTDput | $689,000 | – | 29,700 | +100.0% | 0.33% | – |
| FOMX | New | FOAMIX PHARMACEUTICALS LTD | $646,000 | – | 139,200 | +100.0% | 0.31% | – |
| ADMP | Sell | ADAMIS PHARMACEUTICALS CORP | $637,000 | -83.0% | 122,506 | -86.1% | 0.30% | -85.6% |
| AGLE | Sell | AEGLEA BIO THERAPEUTICS INC | $499,000 | -60.6% | 129,583 | -23.7% | 0.24% | -66.5% |
| PFNX | PFENEX INC | $344,000 | -31.1% | 85,867 | 0.0% | 0.16% | -41.6% | |
| PHG | New | KONINKLIJKE PHILIPS NVcall | $319,000 | – | 8,900 | +100.0% | 0.15% | – |
| OASMY | Buy | OASMIA PHARMACEUTICAL ABadr | $214,000 | -43.2% | 203,170 | +2.9% | 0.10% | -51.7% |
| SNSS | Sell | SUNESIS PHARMACEUTICALS INC | $91,000 | -92.9% | 33,710 | -89.2% | 0.04% | -94.0% |
| ANTH | Exit | ANTHERA PHARMACEUTICALS INC | $0 | – | -333,712 | -100.0% | -0.08% | – |
| BPMX | Exit | BIOPHARMX CORP | $0 | – | -313,717 | -100.0% | -0.09% | – |
| FWP | Exit | FORWARD PHARMA A/Ssponsored adr | $0 | – | -14,224 | -100.0% | -0.17% | – |
| NLNK | Exit | NEWLINK GENETICS CORP | $0 | – | -25,420 | -100.0% | -0.34% | – |
| ALNY | Exit | ALNYLAM PHARMACEUTICALS INCput | $0 | – | -13,500 | -100.0% | -0.39% | – |
| CERN | Exit | CERNER CORPput | $0 | – | -20,000 | -100.0% | -0.66% | – |
| CHRS | Exit | COHERUS BIOSCIENCES INC | $0 | – | -63,800 | -100.0% | -0.76% | – |
| ITEK | Exit | INOTEK PHARMACEUTICALS CORP | $0 | – | -726,900 | -100.0% | -0.81% | – |
| Q | Exit | QUINTILES IMS HOLDINGS INCput | $0 | – | -21,500 | -100.0% | -0.97% | – |
| VRTX | Exit | VERTEX PHARMACEUTICALS INC | $0 | – | -19,475 | -100.0% | -1.19% | – |
| TEVA | Exit | TEVA PHARMACEUTICAL INDUSTRIES LTDsponsored adr | $0 | – | -69,500 | -100.0% | -1.25% | – |
| BSX | Exit | BOSTON SCIENTIFIC CORP | $0 | – | -90,000 | -100.0% | -1.25% | – |
| MOH | Exit | MOLINA HEALTHCARE INCcall | $0 | – | -50,000 | -100.0% | -1.28% | – |
| PFE | Exit | PFIZER INCput | $0 | – | -100,000 | -100.0% | -1.91% | – |
| CAH | Exit | CARDINAL HEALTH INC | $0 | – | -57,950 | -100.0% | -2.64% | – |
| MRK | Exit | MERCK & CO INCput | $0 | – | -80,000 | -100.0% | -2.84% | – |
| BIIB | Exit | BIOGEN INC | $0 | – | -27,650 | -100.0% | -4.23% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VIKING THERAPEUTICS INC | 24 | Q3 2023 | 3.4% |
| UNITED THERAPEUTICS ORD | 23 | Q3 2023 | 8.3% |
| CARDINAL HEALTH ORD | 20 | Q2 2022 | 7.2% |
| SANOFI SA | 19 | Q3 2022 | 9.8% |
| MEDTRONIC PLC | 18 | Q3 2023 | 5.2% |
| CATALYST BIOSCIENCES INC | 18 | Q3 2021 | 17.8% |
| PFENEX ORD | 18 | Q4 2019 | 5.9% |
| AEGLEA BIOTHERAPEUTICS INC | 18 | Q1 2023 | 1.1% |
| HCA HEALTHCARE INC | 17 | Q2 2022 | 5.5% |
| MCKESSON ORD | 17 | Q1 2022 | 6.0% |
View Sio Capital Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Modular Medical, Inc. | February 13, 2023 | 1,091,479 | 10.0% |
| Cellectar Biosciences, Inc. | February 10, 2022 | ? | ? |
| CURIS INC | February 10, 2022 | 3,866,645 | 4.2% |
| Salarius Pharmaceuticals, Inc. | February 10, 2022 | 1,354,291 | 3.0% |
| Larimar Therapeutics, Inc. | February 16, 2021 | 188,661 | 1.2% |
| ACHIEVE LIFE SCIENCES, INC. | February 14, 2020 | ? | ? |
| Bionano Genomics, Inc | February 14, 2020 | 1,210,821 | 4.6% |
| Brickell Biotech, Inc. | February 14, 2020 | ? | ? |
| Trillium Therapeutics Inc. | February 14, 2020 | 2,751,186 | 9.8% |
| ZAFGEN, INC. | February 14, 2020 | 2,283,164 | 6.1% |
View Sio Capital Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| SC 13G | 2023-02-13 |
| 13F-HR | 2022-11-14 |
View Sio Capital Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.